REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ucb Pharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Warehousing and Storage
Full name: Ucb Pharma Sp. z o.o. Profile Updated: January 03, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Ucb Pharma Sp. z o.o. is a pharmaceutical company that specializes in developing and offering cardiological products and other drugs to meet the changing needs of patients. It operates in the pharmaceutical industry and targets people whose lives have been disturbed by diseases, providing them with health care.

Headquarters
Ul. Leona Kruczkowskiego 8
Warsaw; Mazowieckie; Postal Code: 00-380

Contact Details: Purchase the Ucb Pharma Sp. z o.o. report to view the information.

Website: http://www.ucb.pl

Basic Information
Total Employees:
Purchase the Ucb Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ucb Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Ucb Pharma Sp. z o.o. report to view the information.
Incorporation Date:
July 08, 2002
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
W Organie Prezes Zarzadu Reprezentujacym
Ownership Details
Purchase this report to view the information.
78.05%
Purchase this report to view the information.
21.95%
Company Performance
Financial values in the chart are available after Ucb Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
17.92%▲
Total operating revenue
17.79%▲
Operating Profit/Loss (EBIT)
-2.16%▼
EBITDA
-2.16%▼
Net Profit/Loss for the Period
-10.79%▼
Total Assets
19.67%▲
Total Equity
-1.58%▼
Operating Profit Margin (ROS)
-0.84%▼
Net Profit Margin
-0.97%▼
Return on Equity (ROE)
-1.37%▼
Quick Ratio
-0.3%▼
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo